The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Changes to Warrant Terms

18 Jan 2022 07:00

RNS Number : 7425Y
Sabien Technology Group PLC
18 January 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

18 January 2022

Sabien Technology Group plc

("Sabien" or the "Company")

Changes to Warrant Terms

 

Sabien Technology Group plc, a Company focused on a Green Aggregation Strategy announces that the board of directors of the Company (the "Board") yesterday agreed to amend the terms of the warrants originally announced on 20 January 2021 (the "Warrants"). Following last year's share capital consolidation and those warrant exercises that have taken place so far, there are 8,283,331 Warrants outstanding. The Warrant terms will be amended as follows:

· The final exercise date will be extended from 19 January 2022 to 4 February 2022; and

· Any Warrant holder who exercises at least 25% of their Warrants between 20 January 2022 and 2 February 2022 will be granted one Bonus Warrant for each Warrant exercised.

All other Warrant terms will remain unchanged. The Bonus Warrants will have the following key terms:

· An exercise period which expires on 5 February 2023;

· An exercise price of 45 pence per new ordinary share of 3 pence each in the capital of the Company ("Ordinary Shares");

· Transferrable (however no application will be made for admission to trading on any recognised trading platform); and

· The Bonus Warrants will have a call option whereby in the event that the Ordinary Shares closes above 40 pence per Ordinary Share (mid-market closing price on AIM), the Company has the right (but not the obligation) at any time thereafter to call warrant holders to exercise all warrants held by them within 7 days. Any warrants not exercised when so required by the Company will automatically expire at the end of the 7-day period.

 

Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman

 

+44 20 7993 3700

 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj

 

+44 20 3328 5656

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams

+44 20 7469 0930

 

The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman.

A copy of this announcement will be available from the Company's website at www.sabien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBVARUAUAAUR
Date   Source Headline
12th Oct 20227:00 amRNSHolding(s) in Company
5th Oct 20223:33 pmRNSHolding(s) in Company
23rd Sep 20222:49 pmRNSHolding(s) in Company
20th Sep 20224:16 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSRevised Date for Summit for S'th Korean Delegation
31st Aug 20225:00 pmRNSTotal Voting Rights
25th Aug 20223:30 pmRNSAdmission to trading of new Ordinary Shares
22nd Aug 20226:24 pmRNSResult of General Meeting
19th Aug 20227:00 amRNSSales Channel Partnership
16th Aug 20227:00 amRNSHolding(s) in Company
16th Aug 20227:00 amRNSExtension of Sales Agency Agreement
5th Aug 20225:15 pmRNSNotice of GM & Holdings in the Company
4th Aug 20227:00 amRNSOversubscribed Broker Option to raise £100,000
3rd Aug 20227:00 amRNSPlacing to raise £500,000 & Broker Option
8th Jul 202212:45 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update
7th Jun 20227:00 amRNSHolding(s) in Company
13th May 20227:00 amRNSWelsh Freeport
5th May 20227:00 amRNSUpdate on b.grn
11th Apr 20221:00 pmRNSCorporate Update - Contract Win
4th Apr 20225:00 pmRNSProject COFFEE - Replacement
4th Apr 20222:30 pmRNSProject COFFEE
31st Mar 20224:02 pmRNSHalf-year Report
31st Mar 20227:00 amRNSHolding(s) in Company
25th Mar 20227:00 amRNSContract Win
3rd Feb 20222:03 pmRNSHolding(s) in Company
2nd Feb 20227:00 amRNSMOU signed with Irish Renewable Fuels Ltd.
1st Feb 20222:43 pmRNSLicence agreement with Proton Technologies Canada
18th Jan 20227:00 amRNSChanges to Warrant Terms
14th Jan 20224:25 pmRNSHolding(s) in Company
31st Dec 202112:00 pmRNSTotal Voting Rights
22nd Dec 20217:00 amRNSAgreement for Establishment of SPV
26th Nov 20217:00 amRNSWarrant Exercise
11th Nov 20217:00 amRNSLicence agreement with Proton Technologies
4th Nov 20217:00 amRNSRole of Carbon Credits, Blockchain & Carbon Market
1st Nov 20217:00 amRNSCOP26: Sabien hosts Green Economics Debate
29th Oct 20215:00 pmRNSTotal Voting Rights
14th Oct 20213:00 pmRNSResult of AGM
14th Oct 202110:00 amRNSSabien Presentation at FTE Mykonos
14th Oct 20218:00 amRNSIssue of Equity
14th Oct 20217:30 amRNSAGM Statement
14th Oct 20217:00 amRNSSubscription and possible Co-operation Agreement
21st Sep 20217:00 amRNSHolding(s) in Company
16th Sep 20211:02 pmRNSAeristech: Investor Update
16th Sep 202111:30 amRNSHolding(s) in Company
15th Sep 20217:00 amRNSSales Agency Agreement
14th Sep 20216:00 pmRNSPosting of Annual Report & Notice of AGM
31st Aug 20217:12 amRNSFinal Results for the year to 30 June 2021
31st Aug 20217:00 amRNSFinal Results for the Year to 30 June 2021
10th Aug 202112:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.